Back to funds

Defilade Capital Management, L.P.

Updated 6 days ago

Managed by Defilade Capital Management, L.P. • Latest filing Q3 2026

Portfolio value
$598.8M
Q3 2026
Filings
4
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
—
Implied from 13F holdings

Portfolio value history

13F-disclosed portfolio value over 4 quarters

Show data table
PeriodPortfolio value
Q4 2025$737.7M
Q1 2026$712.2M
Q2 2026$746.9M
Q3 2026$598.8M

Top holdings

30 positions as of Q3 2026

View filing
P

PFIZER INC

Value
$43.5M
Shares
1.52M
% Port
7.26%
L

ELI LILLY & CO

Value
$40.2M
Shares
34.8K
% Port
6.72%
B

BIOMARIN PHARMACEUTICAL INC

Value
$36.1M
Shares
601.9K
% Port
6.03%
G

GILEAD SCIENCES INC

Value
$33.8M
Shares
226.6K
% Port
5.64%
A

AXSOME THERAPEUTICS INC.

Value
$32.3M
Shares
175.4K
% Port
5.40%
A

AMGEN INC

Value
$31.2M
Shares
74.1K
% Port
5.21%
O

ORIC PHARMACEUTICALS INC

Value
$30.6M
Shares
2.27M
% Port
5.11%
A

ASCENDIS PHARMA A/S

Value
$29.4M
Shares
128.9K
% Port
4.90%
I

INTUITIVE SURGICAL INC

Value
$29.2M
Shares
71.9K
% Port
4.88%
S

STRYKER CORPORATION

Value
$22.5M
Shares
81.5K
% Port
3.75%
V

VERA THERAPEUTICS INC

Value
$21.1M
Shares
652.4K
% Port
3.52%
C

COGENT BIOSCIENCES INC

Value
$20.2M
Shares
631.6K
% Port
3.38%
V

VEEVA SYS INC

Value
$19.7M
Shares
69.1K
% Port
3.30%
R

ROYALTY PHARMA PLC

Value
$19.4M
Shares
332.2K
% Port
3.24%
M

AGIOS PHARMACEUTICALS INC

Value
$19M
Shares
570.3K
% Port
3.17%
T

THERMO FISHER SCIENTIFIC INC

Value
$17.9M
Shares
26.5K
% Port
2.98%
O

OCULAR THERAPEUTIX INC

Value
$17.5M
Shares
2.28M
% Port
2.91%
L

LARIMAR THERAPEUTICS INC

Value
$15.8M
Shares
4.93M
% Port
2.63%
B

BOSTON SCIENTIFIC CORP

Value
$15.3M
Shares
350.8K
% Port
2.56%
R

REVOLUTION MEDICINES INC

Value
$14.6M
Shares
71.2K
% Port
2.44%

Explore